
A new daily tablet designed to alleviate hot flushes and night sweats could offer a significant breakthrough for around 500,000 menopausal women, health officials have indicated.
The non-hormonal treatment, known as Fezolinetant (or Veoza), has been approved by the National Institute for Health and Care Excellence (NICE) for prescription on the NHS. It is specifically intended for individuals for whom traditional hormone replacement therapy (HRT) is unsuitable.